InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by LAROSA JOSEPH J, Vice-Président Exécutif, Conseiller Juridique et Secrétaire. Officer active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 10 disclosures have been recorded. Total volume traded: €3.6m. The latest transaction was disclosed on 7 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€3m5,114 shares@ €663.70050.0046% mcap32.2% of flow
Common Stock
SEC:0001708138-22-000040:0·
€228,521369 shares@ €619.2990.0003% mcap2.2% of flow
Common Stock
SEC:0001708138-22-000033:0·
€410,017697 shares@ €588.25980.0006% mcap11.9% of flow
Common Stock
SEC:0001708138-21-000103·
€410,017697 shares@ €588.25980.0006% mcap3.9% of flow
Common Stock
SEC:0001708138-21-000103:0·
03,338 shares0
Common Stock
SEC:0001883850-21-000023·
03,338 shares0
Common Stock
SEC:0001883850-21-000023:0·
€2m10,000 shares@ €153.40940.0021% mcap44.4% of flow
Common Stock
SEC:0001237899-21-000018·
€2m10,000 shares@ €153.40940.0021% mcap14.6% of flow
Common Stock
SEC:0001237899-21-000018:0·
€2m10,000 shares@ €151.21260.0021% mcap43.8% of flow
Common Stock
SEC:0001708138-21-000036·
€2m10,000 shares@ €151.21260.0021% mcap14.4% of flow
Common Stock
SEC:0001708138-21-000036:0·
10 of 10 declarations
About LAROSA JOSEPH J
Joseph J. LaRosa is the EVP General Counsel and Secretary at Regeneron Pharmaceuticals, Inc. He is responsible for overseeing the company's legal affairs and plays a crucial role in managing legal and regulatory risks. His expertise contributes to compliance and the legal strategy of Regeneron.
